Gsk (GSK) Research & Development (2009 - 2026)
Gsk (GSK) posted Research & Development of -$6.93 billion for the quarter ended Sep 8, 2026.
Powered by 
Analysis
Gsk (GSK) Research & Development (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 8, 2026, Research & Development at Gsk was -$23.87 billion; for the year ended Dec 31, 2025, it was -$9.92 billion.
- In prior years, Gsk's Research & Development was -$8.18 billion in the year ended Dec 31, 2024, -$7.74 billion in the year ended Dec 31, 2023, -$6.79 billion in the year ended Dec 31, 2022 and -$6.91 billion in the year ended Dec 31, 2021.
- Quarterly Research & Development has run from a low of -$10.01 billion in the quarter ended Dec 31, 2025 to a high of -$1.48 billion in the quarter ended Mar 31, 2022 over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | -2.85 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | -4.05 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | -4.65 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.65 Bn |
| Mar 31, 2026 | -2.28 Bn |
| Dec 31, 2025 | -10.01 Bn |
| Sep 30, 2025 | -2.28 Bn |
| Jun 30, 2025 | -2.70 Bn |
| Mar 31, 2025 | -1.84 Bn |
| Dec 31, 2024 | -8.22 Bn |
| Sep 30, 2024 | -1.90 Bn |
| Jun 30, 2024 | -1.86 Bn |
| Mar 31, 2024 | -1.82 Bn |
| Dec 31, 2023 | -7.72 Bn |
| Sep 30, 2023 | -2.00 Bn |
| Jun 30, 2023 | -1.68 Bn |
| Mar 31, 2023 | -1.53 Bn |
| Dec 31, 2022 | -6.44 Bn |
| Sep 30, 2022 | -1.59 Bn |
| Jun 30, 2022 | -1.56 Bn |
| Mar 31, 2022 | -1.48 Bn |
| Dec 31, 2021 | -1.85 Bn |
| Sep 30, 2021 | -1.95 Bn |
API Access
Gsk Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();